We are live on
!
Find out more
HM
HealthCor Management Portfolio holdings
AUM
$109M
1-Year Est. Return
10.64%
This Fund
S&P 500
This Quarter
Est. Return
-8.51%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$995M
AUM Growth
-$504M
(-34%)
Cap. Flow
-$395M
Cap. Flow
% of AUM
-39.65%
Top 10 Holdings %
Top 10 Hldgs %
49.03%
Holding
79
New
15
Increased
11
Reduced
25
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$29.9M |
| 2 |
Cigna
CI
|
+$24.9M |
| 3 |
Eli Lilly
LLY
|
+$21.2M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$18.3M |
| 5 |
Intuitive Surgical
ISRG
|
+$17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Envista
NVST
|
+$44.5M |
| 2 |
AbbVie
ABBV
|
+$41.2M |
| 3 |
Teleflex
TFX
|
+$35.2M |
| 4 |
Abbott
ABT
|
+$32.4M |
| 5 |
CVS Health
CVS
|
+$29M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 93.68% |
| 2 | Financials | 0.12% |
| 3 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Petco
WOOF
$780M
| – | – |
-1,215,000
| Closed | -$23.8M |
|
77
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.2B
| – | – |
-600,000
| Closed | -$53.9M |
|
|
CANO
78
DELISTED
Cano Health, Inc.
CANO
| – | – |
-7,120
| Closed | -$4.52M |
|
|
RACB
79
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
| – | – |
-1,324,800
| Closed | -$12.9M |
|
Similar funds
IA
EPC
TCMV
SI
HCWM
PC
RF
AWM
HealthCor Management's Q2 2022 Portfolio in Review
As of Q2 2022, HealthCor Management held 79 positions worth $995M, down 34% from $1.5B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
HealthCor Management withdrew a net $395M in Q2 2022, closing 21 positions and reducing 25 holdings. Its most notable exit was Envista, an estimated $44.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 92% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, HealthCor Management opened a new position in Hologic worth $27.9M.
- HealthCor Management's largest Q2 2022 buy was Hologic: 402,110 shares worth $27.9M.
- HealthCor Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2022, an estimated $18.3M increase.
- HealthCor Management's biggest Q2 2022 reduction was Abbott, cutting an estimated $32.4M.
- HealthCor Management fully exited Envista in Q2 2022, selling an estimated $44.5M.
- HealthCor Management's ten largest holdings make up 49% of its $995M portfolio in Q2 2022.
- HealthCor Management opened 15 new positions and closed 21 in Q2 2022.
- HealthCor Management's portfolio value fell 34% quarter-over-quarter to $995M.
Based on HealthCor Management's 13F filing for Q2 2022, filed 15 Aug 2022.